All Stories

Biopharma briefing: Q1 trends, gene therapy updates and ASCO preview

This week on "The Top Line," we break down first-quarter Big Pharma earnings, recap the latest gene therapy developments and preview what’s ahead at ASCO.

May 30, 2025 - 16:10
 0
Biopharma briefing: Q1 trends, gene therapy updates and ASCO preview
This week on "The Top Line," we break down first-quarter Big Pharma earnings, recap the latest gene therapy developments and preview what’s ahead at ASCO.
Read More

Tags:

Previous Article

Senator grills Makary over FDA’s ability to regulate drug ads after OPDP cuts

Next Article

Merck plays lion tamer, taking middle dose of ROR ADC forward in relapsed or ref...

Related Posts

Sanofi hops on the US investment bandwagon with $20B commitment through 2030

Sanofi hops on the US investment bandwagon with $20B co...

May 14, 2025  0

Novo heads to regulators after Sogroya matches predecessor Norditropin in 3 pediatric growth disorders

Novo heads to regulators after Sogroya matches predeces...

May 13, 2025  0

After Keytruda combo win, Gilead's Trodelvy meets the mark in solo breast cancer trial

After Keytruda combo win, Gilead's Trodelvy meets the m...

May 23, 2025  0